TTM
18.8%
YoY change
+12.85pp
Trough year (2023)
-9.2%
Peak year (2008)
31.2%
Latest annual
13.8%
FCF Margin history chart for Eli Lilly (LLY) from 1989 to 2025
Latest: 13.8%
FCF Margin change chart for Eli Lilly (LLY) from 1989 to 2025
Latest: +12.85pp
FCF Margin history table for Eli Lilly (LLY) from 1989 to 2025
| 2025 | 13.8% | +12.85pp | ||
| 2024 | 0.9% | +10.16pp | ||
| 2023 | -9.2% | -25.36pp | ||
| 2022 | 16.1% | -2.91pp | ||
| 2021 | 19.0% | +0.81pp | ||
| 2020 | 18.2% | +2.61pp | ||
| 2019 | 15.6% | +3.94pp | ||
| 2018 | 11.7% | -5.62pp | ||
| 2017 | 17.3% | -0.43pp | ||
| 2016 | 17.7% | +11.01pp | ||
| 2015 | 6.7% | -8.04pp | ||
| 2014 | 14.7% | -5.34pp | ||
| 2013 | 20.1% | +1.23pp | ||
| 2012 | 18.8% | -3.97pp | ||
| 2011 | 22.8% | -1.75pp | ||
| 2010 | 24.6% | +8.63pp | ||
| 2009 | 15.9% | -15.22pp | ||
| 2008 | 31.2% | +9.31pp | ||
| 2007 | 21.9% | +3.38pp | ||
| 2006 | 18.5% | +14.27pp | ||
| 2005 | 4.2% | -2.81pp | ||
| 2004 | 7.0% | -8.41pp | ||
| 2003 | 15.4% | +6.94pp | ||
| 2002 | 8.5% | -15.58pp | ||
| 2001 | 24.1% | -4.05pp | ||
| 2000 | 28.1% | +7.20pp | ||
| 1999 | 20.9% | -3.02pp | ||
| 1998 | 23.9% | -1.54pp | ||
| 1997 | 25.5% | +3.35pp | ||
| 1996 | 22.1% | +3.29pp | ||
| 1995 | 18.8% | +2.09pp | ||
| 1994 | 16.7% | +3.04pp | ||
| 1993 | 13.7% | +5.89pp | ||
| 1992 | 7.8% | +5.85pp | ||
| 1991 | 2.0% | -7.04pp | ||
| 1990 | 9.0% | -2.45pp | ||
| 1989 | 11.4% | — |
- 202513.8%+12.85pp
- 20240.9%+10.16pp
- 2023-9.2%-25.36pp
- 202216.1%-2.91pp
- 202119.0%+0.81pp
- 202018.2%+2.61pp
- 201915.6%+3.94pp
- 201811.7%-5.62pp
- 201717.3%-0.43pp
- 201617.7%+11.01pp
- 20156.7%-8.04pp
- 201414.7%-5.34pp
- 201320.1%+1.23pp
- 201218.8%-3.97pp
- 201122.8%-1.75pp
- 201024.6%+8.63pp
- 200915.9%-15.22pp
- 200831.2%+9.31pp
- 200721.9%+3.38pp
- 200618.5%+14.27pp
- 20054.2%-2.81pp
- 20047.0%-8.41pp
- 200315.4%+6.94pp
- 20028.5%-15.58pp
- 200124.1%-4.05pp
- 200028.1%+7.20pp
- 199920.9%-3.02pp
- 199823.9%-1.54pp
- 199725.5%+3.35pp
- 199622.1%+3.29pp
- 199518.8%+2.09pp
- 199416.7%+3.04pp
- 199313.7%+5.89pp
- 19927.8%+5.85pp
- 19912.0%-7.04pp
- 19909.0%-2.45pp
- 198911.4%—
FCF Margin values are taken from Eli Lilly's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported free cash flow margin is 18.8%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Eli Lilly (LLY) reported free cash flow margin of 13.77% – expanded 12.8 percentage points year-over-year.
2008 marks the peak free cash flow margin at 31.16%, with the historical low of -9.24% recorded in 2023.
Eli Lilly FCF Margin by Year
Eli Lilly FCF Margin 2025: 13.8%
In 2025, Eli Lilly reported free cash flow margin of 13.77%, expanded 12.8 percentage points from 2024.
Eli Lilly FCF Margin 2024: 0.9%
Eli Lilly free cash flow margin in 2024 was 0.92%, expanded 10.2 percentage points from 2023.
Eli Lilly FCF Margin 2023: -9.2%
2023's free cash flow margin for Eli Lilly came in at -9.24%, contracted 25.4 percentage points from 2022. This figure represents the lowest annual value in the available history.
Eli Lilly FCF Margin 2022: 16.1%
Eli Lilly posted free cash flow margin of 16.12% in 2022, contracted 2.9 percentage points from 2021.
Eli Lilly FCF Margin 2021: 19.0%
Eli Lilly free cash flow margin in 2021 was 19.02%.
See more financial history for Eli Lilly (LLY).
Sector peers by FCF Margin
Healthcare peers of Eli Lilly (LLY), ranked by their latest free cash flow margin
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation